nodes	percent_of_prediction	percent_of_DWPC	metapath
Polythiazide—Hyperuricaemia—Tretinoin—peripheral nervous system neoplasm	0.0152	0.0152	CcSEcCtD
Polythiazide—Hyperuricaemia—Isotretinoin—peripheral nervous system neoplasm	0.0152	0.0152	CcSEcCtD
Polythiazide—Hyperuricaemia—Melphalan—peripheral nervous system neoplasm	0.015	0.015	CcSEcCtD
Polythiazide—Vasculitis—Isotretinoin—peripheral nervous system neoplasm	0.0145	0.0145	CcSEcCtD
Polythiazide—Vasculitis—Tretinoin—peripheral nervous system neoplasm	0.0145	0.0145	CcSEcCtD
Polythiazide—Blood uric acid increased—Tretinoin—peripheral nervous system neoplasm	0.0144	0.0144	CcSEcCtD
Polythiazide—Blood uric acid increased—Isotretinoin—peripheral nervous system neoplasm	0.0144	0.0144	CcSEcCtD
Polythiazide—Vasculitis—Melphalan—peripheral nervous system neoplasm	0.0143	0.0143	CcSEcCtD
Polythiazide—Blood uric acid increased—Melphalan—peripheral nervous system neoplasm	0.0142	0.0142	CcSEcCtD
Polythiazide—Photosensitivity—Tretinoin—peripheral nervous system neoplasm	0.0117	0.0117	CcSEcCtD
Polythiazide—Photosensitivity—Isotretinoin—peripheral nervous system neoplasm	0.0117	0.0117	CcSEcCtD
Polythiazide—Hyperuricaemia—Alitretinoin—peripheral nervous system neoplasm	0.0115	0.0115	CcSEcCtD
Polythiazide—Hyperuricaemia—Vincristine—peripheral nervous system neoplasm	0.0111	0.0111	CcSEcCtD
Polythiazide—Vasculitis—Alitretinoin—peripheral nervous system neoplasm	0.011	0.011	CcSEcCtD
Polythiazide—Blood uric acid increased—Alitretinoin—peripheral nervous system neoplasm	0.0109	0.0109	CcSEcCtD
Polythiazide—Aplastic anaemia—Dactinomycin—peripheral nervous system neoplasm	0.0108	0.0108	CcSEcCtD
Polythiazide—Blood uric acid increased—Vincristine—peripheral nervous system neoplasm	0.0105	0.0105	CcSEcCtD
Polythiazide—Hyperuricaemia—Cisplatin—peripheral nervous system neoplasm	0.00983	0.00983	CcSEcCtD
Polythiazide—Cramp muscle—Topotecan—peripheral nervous system neoplasm	0.00931	0.00931	CcSEcCtD
Polythiazide—Blood uric acid increased—Cisplatin—peripheral nervous system neoplasm	0.00929	0.00929	CcSEcCtD
Polythiazide—Hyperuricaemia—Etoposide—peripheral nervous system neoplasm	0.00901	0.00901	CcSEcCtD
Polythiazide—Photosensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00885	0.00885	CcSEcCtD
Polythiazide—Pancreatitis—Tretinoin—peripheral nervous system neoplasm	0.00869	0.00869	CcSEcCtD
Polythiazide—Pancreatitis—Isotretinoin—peripheral nervous system neoplasm	0.00869	0.00869	CcSEcCtD
Polythiazide—Blood uric acid increased—Etoposide—peripheral nervous system neoplasm	0.00851	0.00851	CcSEcCtD
Polythiazide—Photosensitivity reaction—Tretinoin—peripheral nervous system neoplasm	0.00809	0.00809	CcSEcCtD
Polythiazide—Photosensitivity reaction—Isotretinoin—peripheral nervous system neoplasm	0.00809	0.00809	CcSEcCtD
Polythiazide—Jaundice—Melphalan—peripheral nervous system neoplasm	0.0076	0.0076	CcSEcCtD
Polythiazide—Agranulocytosis—Tretinoin—peripheral nervous system neoplasm	0.00737	0.00737	CcSEcCtD
Polythiazide—Agranulocytosis—Isotretinoin—peripheral nervous system neoplasm	0.00737	0.00737	CcSEcCtD
Polythiazide—Pancreatitis—Alitretinoin—peripheral nervous system neoplasm	0.00659	0.00659	CcSEcCtD
Polythiazide—Photosensitivity reaction—Alitretinoin—peripheral nervous system neoplasm	0.00613	0.00613	CcSEcCtD
Polythiazide—Orthostatic hypotension—Cisplatin—peripheral nervous system neoplasm	0.00605	0.00605	CcSEcCtD
Polythiazide—Agranulocytosis—Dactinomycin—peripheral nervous system neoplasm	0.00603	0.00603	CcSEcCtD
Polythiazide—Muscle spasms—Topotecan—peripheral nervous system neoplasm	0.00599	0.00599	CcSEcCtD
Polythiazide—Cramp muscle—Cisplatin—peripheral nervous system neoplasm	0.00596	0.00596	CcSEcCtD
Polythiazide—Photosensitivity reaction—Vincristine—peripheral nervous system neoplasm	0.00591	0.00591	CcSEcCtD
Polythiazide—Glycosuria—Epirubicin—peripheral nervous system neoplasm	0.00578	0.00578	CcSEcCtD
Polythiazide—Agitation—Tretinoin—peripheral nervous system neoplasm	0.00568	0.00568	CcSEcCtD
Polythiazide—Agitation—Isotretinoin—peripheral nervous system neoplasm	0.00568	0.00568	CcSEcCtD
Polythiazide—Pancreatitis—Cisplatin—peripheral nervous system neoplasm	0.00561	0.00561	CcSEcCtD
Polythiazide—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.00559	0.00559	CcSEcCtD
Polythiazide—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.00557	0.00557	CcSEcCtD
Polythiazide—Cramp muscle—Etoposide—peripheral nervous system neoplasm	0.00546	0.00546	CcSEcCtD
Polythiazide—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00546	0.00546	CcSEcCtD
Polythiazide—Glycosuria—Doxorubicin—peripheral nervous system neoplasm	0.00535	0.00535	CcSEcCtD
Polythiazide—Jaundice cholestatic—Epirubicin—peripheral nervous system neoplasm	0.00533	0.00533	CcSEcCtD
Polythiazide—Hyperuricaemia—Epirubicin—peripheral nervous system neoplasm	0.00505	0.00505	CcSEcCtD
Polythiazide—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00497	0.00497	CcSEcCtD
Polythiazide—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00493	0.00493	CcSEcCtD
Polythiazide—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00493	0.00493	CcSEcCtD
Polythiazide—Jaundice cholestatic—Doxorubicin—peripheral nervous system neoplasm	0.00493	0.00493	CcSEcCtD
Polythiazide—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00487	0.00487	CcSEcCtD
Polythiazide—Anorexia—Topotecan—peripheral nervous system neoplasm	0.00484	0.00484	CcSEcCtD
Polythiazide—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.0048	0.0048	CcSEcCtD
Polythiazide—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.0048	0.0048	CcSEcCtD
Polythiazide—Blood uric acid increased—Epirubicin—peripheral nervous system neoplasm	0.00477	0.00477	CcSEcCtD
Polythiazide—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00474	0.00474	CcSEcCtD
Polythiazide—Hyperuricaemia—Doxorubicin—peripheral nervous system neoplasm	0.00467	0.00467	CcSEcCtD
Polythiazide—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.00456	0.00456	CcSEcCtD
Polythiazide—Jaundice—Etoposide—peripheral nervous system neoplasm	0.00456	0.00456	CcSEcCtD
Polythiazide—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00453	0.00453	CcSEcCtD
Polythiazide—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00453	0.00453	CcSEcCtD
Polythiazide—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00452	0.00452	CcSEcCtD
Polythiazide—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00447	0.00447	CcSEcCtD
Polythiazide—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00442	0.00442	CcSEcCtD
Polythiazide—Blood uric acid increased—Doxorubicin—peripheral nervous system neoplasm	0.00441	0.00441	CcSEcCtD
Polythiazide—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.0044	0.0044	CcSEcCtD
Polythiazide—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00438	0.00438	CcSEcCtD
Polythiazide—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00438	0.00438	CcSEcCtD
Polythiazide—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00436	0.00436	CcSEcCtD
Polythiazide—Constipation—Topotecan—peripheral nervous system neoplasm	0.00434	0.00434	CcSEcCtD
Polythiazide—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00432	0.00432	CcSEcCtD
Polythiazide—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00431	0.00431	CcSEcCtD
Polythiazide—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00431	0.00431	CcSEcCtD
Polythiazide—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.0043	0.0043	CcSEcCtD
Polythiazide—Agitation—Vincristine—peripheral nervous system neoplasm	0.00414	0.00414	CcSEcCtD
Polythiazide—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00407	0.00407	CcSEcCtD
Polythiazide—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00405	0.00405	CcSEcCtD
Polythiazide—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00404	0.00404	CcSEcCtD
Polythiazide—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00404	0.00404	CcSEcCtD
Polythiazide—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00403	0.00403	CcSEcCtD
Polythiazide—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.004	0.004	CcSEcCtD
Polythiazide—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.004	0.004	CcSEcCtD
Polythiazide—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00395	0.00395	CcSEcCtD
Polythiazide—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00393	0.00393	CcSEcCtD
Polythiazide—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.00387	0.00387	CcSEcCtD
Polythiazide—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00383	0.00383	CcSEcCtD
Polythiazide—Vascular purpura—Epirubicin—peripheral nervous system neoplasm	0.0038	0.0038	CcSEcCtD
Polythiazide—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00374	0.00374	CcSEcCtD
Polythiazide—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00374	0.00374	CcSEcCtD
Polythiazide—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00371	0.00371	CcSEcCtD
Polythiazide—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00371	0.00371	CcSEcCtD
Polythiazide—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00367	0.00367	CcSEcCtD
Polythiazide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00365	0.00365	CcSEcCtD
Polythiazide—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00364	0.00364	CcSEcCtD
Polythiazide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00362	0.00362	CcSEcCtD
Polythiazide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00362	0.00362	CcSEcCtD
Polythiazide—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.0036	0.0036	CcSEcCtD
Polythiazide—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00358	0.00358	CcSEcCtD
Polythiazide—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00358	0.00358	CcSEcCtD
Polythiazide—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00357	0.00357	CcSEcCtD
Polythiazide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00357	0.00357	CcSEcCtD
Polythiazide—Purpura—Epirubicin—peripheral nervous system neoplasm	0.00353	0.00353	CcSEcCtD
Polythiazide—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.00352	0.00352	CcSEcCtD
Polythiazide—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00351	0.00351	CcSEcCtD
Polythiazide—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00351	0.00351	CcSEcCtD
Polythiazide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00348	0.00348	CcSEcCtD
Polythiazide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Polythiazide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Polythiazide—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00343	0.00343	CcSEcCtD
Polythiazide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.0034	0.0034	CcSEcCtD
Polythiazide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00336	0.00336	CcSEcCtD
Polythiazide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00333	0.00333	CcSEcCtD
Polythiazide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00333	0.00333	CcSEcCtD
Polythiazide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00332	0.00332	CcSEcCtD
Polythiazide—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00331	0.00331	CcSEcCtD
Polythiazide—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00328	0.00328	CcSEcCtD
Polythiazide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00327	0.00327	CcSEcCtD
Polythiazide—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00327	0.00327	CcSEcCtD
Polythiazide—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.00326	0.00326	CcSEcCtD
Polythiazide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00323	0.00323	CcSEcCtD
Polythiazide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Polythiazide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Polythiazide—Rash—Topotecan—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Polythiazide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Polythiazide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Polythiazide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00319	0.00319	CcSEcCtD
Polythiazide—Headache—Topotecan—peripheral nervous system neoplasm	0.00318	0.00318	CcSEcCtD
Polythiazide—Rash—Tretinoin—peripheral nervous system neoplasm	0.00318	0.00318	CcSEcCtD
Polythiazide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00318	0.00318	CcSEcCtD
Polythiazide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Polythiazide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Polythiazide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00316	0.00316	CcSEcCtD
Polythiazide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00316	0.00316	CcSEcCtD
Polythiazide—Headache—Tretinoin—peripheral nervous system neoplasm	0.00316	0.00316	CcSEcCtD
Polythiazide—Constipation—Vincristine—peripheral nervous system neoplasm	0.00315	0.00315	CcSEcCtD
Polythiazide—Rash—Melphalan—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Polythiazide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00313	0.00313	CcSEcCtD
Polythiazide—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00311	0.00311	CcSEcCtD
Polythiazide—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.0031	0.0031	CcSEcCtD
Polythiazide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Polythiazide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00303	0.00303	CcSEcCtD
Polythiazide—Nausea—Topotecan—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Polythiazide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00299	0.00299	CcSEcCtD
Polythiazide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00299	0.00299	CcSEcCtD
Polythiazide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00296	0.00296	CcSEcCtD
Polythiazide—Nausea—Melphalan—peripheral nervous system neoplasm	0.00295	0.00295	CcSEcCtD
Polythiazide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00292	0.00292	CcSEcCtD
Polythiazide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00292	0.00292	CcSEcCtD
Polythiazide—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.00288	0.00288	CcSEcCtD
Polythiazide—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Polythiazide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00284	0.00284	CcSEcCtD
Polythiazide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00283	0.00283	CcSEcCtD
Polythiazide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00282	0.00282	CcSEcCtD
Polythiazide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00281	0.00281	CcSEcCtD
Polythiazide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00274	0.00274	CcSEcCtD
Polythiazide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00271	0.00271	CcSEcCtD
Polythiazide—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00268	0.00268	CcSEcCtD
Polythiazide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00268	0.00268	CcSEcCtD
Polythiazide—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00267	0.00267	CcSEcCtD
Polythiazide—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00265	0.00265	CcSEcCtD
Polythiazide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00264	0.00264	CcSEcCtD
Polythiazide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Polythiazide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00261	0.00261	CcSEcCtD
Polythiazide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.0026	0.0026	CcSEcCtD
Polythiazide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00259	0.00259	CcSEcCtD
Polythiazide—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00255	0.00255	CcSEcCtD
Polythiazide—Constipation—Etoposide—peripheral nervous system neoplasm	0.00255	0.00255	CcSEcCtD
Polythiazide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Polythiazide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00252	0.00252	CcSEcCtD
Polythiazide—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Polythiazide—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Polythiazide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Polythiazide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Polythiazide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Polythiazide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Polythiazide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Polythiazide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Polythiazide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Polythiazide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Polythiazide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00237	0.00237	CcSEcCtD
Polythiazide—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00236	0.00236	CcSEcCtD
Polythiazide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Polythiazide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Polythiazide—Rash—Vincristine—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Polythiazide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Polythiazide—Headache—Vincristine—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Polythiazide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00227	0.00227	CcSEcCtD
Polythiazide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Polythiazide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Polythiazide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.0022	0.0022	CcSEcCtD
Polythiazide—Nausea—Vincristine—peripheral nervous system neoplasm	0.00219	0.00219	CcSEcCtD
Polythiazide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00214	0.00214	CcSEcCtD
Polythiazide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Polythiazide—Rash—Cisplatin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Polythiazide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Polythiazide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Polythiazide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Polythiazide—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Polythiazide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Polythiazide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Polythiazide—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Polythiazide—Rash—Etoposide—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Polythiazide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Polythiazide—Headache—Etoposide—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Polythiazide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Polythiazide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Polythiazide—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Polythiazide—Nausea—Etoposide—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Polythiazide—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Polythiazide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Polythiazide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Polythiazide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Polythiazide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Polythiazide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Polythiazide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Polythiazide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Polythiazide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Polythiazide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Polythiazide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Polythiazide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Polythiazide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Polythiazide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Polythiazide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00123	0.00123	CcSEcCtD
Polythiazide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00123	0.00123	CcSEcCtD
Polythiazide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Polythiazide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Polythiazide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Polythiazide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Polythiazide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Polythiazide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Polythiazide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Polythiazide—Rash—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Polythiazide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Polythiazide—Headache—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Polythiazide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Polythiazide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000993	0.000993	CcSEcCtD
Polythiazide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000983	0.000983	CcSEcCtD
Polythiazide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000975	0.000975	CcSEcCtD
Polythiazide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000974	0.000974	CcSEcCtD
Polythiazide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000969	0.000969	CcSEcCtD
Polythiazide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000919	0.000919	CcSEcCtD
